Elevance Health Inc.'s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...

The drug’s global sales were estimated to be about $28 billion last year, according to FactSet. Novo Nordisk said Friday it ...

If you have a question about IRMAA or recently got a letter from Social Security about it, let me know. You can write to [email protected]. Craig Cheney travels the country making ...

Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.

On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian ...

UnitedHealth posted a better-than-expected fourth-quarter profit, but a nagging rise in medical costs and care utilization surprised Wall Street. Shares of the health care giant slid early Thursday ...

The four major Medicare parts (A, B, C, D) all offer some prescription drug coverage. Medicare Part D offers the most extensive outpatient prescription drug coverage ...

If you’re age 65 years or older, you can get Medicare coverage and choose from several options: Original Medicare with or without Part D, Medicare Advantage, or Original Medicare with Medigap.

If PCV15 is used, PPSV23 should be administered one year later. Keep in mind that Medicare only pays for one dose of each vaccine. Any additional pneumonia shots, even at the recommendation of your ...

A reader is trying to plan ahead to avoid the dreaded surcharges that can come out of your Social Security check.

FactSet Research Systems FDS stock has had an impressive run over the past six months. Shares have risen 9.4% compared with the industry’s 5.6% growth and the Zacks S&P 500 composite’s 6.3% ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...